Results 181 to 190 of about 199,043 (311)

Reciprocal Associations Between Parental Anxiety/Depression and Emotional/Behavioral Difficulties in Autistic Children Following Their Diagnosis

Autism Research, EarlyView.
ABSTRACT Emotional and behavioral difficulties (EBD) are common in autistic children, while anxiety and depressive symptoms (ADS) are prevalent in their parents. However, the bidirectional relationship between the parents' and children's symptoms remains unclear, especially in the years following the child's autism diagnosis.
Maëva Monnier, Hugo Peyre, Marianne Peries, Valentin Simoncic, Guillaume Nicolet, Cécile Michelon, Yashvin Seetahul, Amaria Baghdadli, on behalf of the Elena Study Group   +8 more
wiley   +1 more source

The Reproductive Autonomy Scale: German validation and application in an Austrian student population. [PDF]

Front Public Health
Böttcher B, Flatscher-Thoeni M, Reiser E, Toth B, Riedl D.   +4 more
europepmc   +1 more source

Efficacy and safety of empagliflozin for treating neutropenia and neutrophil dysfunction in paediatric patients with glycogen storage disease type Ib: A systematic review and meta‐analysis

British Journal of Clinical Pharmacology, EarlyView.
Aims Glycogen storage disease type Ib (GSD‐Ib) is a rare genetic disorder causing neutropenia and neutrophil dysfunction in children. G‐CSF has been the primary treatment, but emerging data support the potential of empagliflozin, an SGLT2 inhibitor, as a promising investigational option.
Elizabeth Iwasyk, Ryan Jin, Fabio Tuzzolino, Giusy Ranucci, Donatella Madonia, Alessio Provenzani   +5 more
wiley   +1 more source

Impact of the COVID-19 Pandemic on School-Based Medical Services in Austria. [PDF]

J Sch Health
Hyll W.
europepmc   +1 more source

Impact of extended insurance coverage on survival outcomes among patients with metastatic colorectal cancer in Taiwan

British Journal of Clinical Pharmacology, EarlyView.
Aims Predetermined treatment duration limits (PTDLs) are often used by Taiwan's National Health Insurance Administration to contain healthcare costs, but they may compromise patient outcomes. Therefore, we studied Taiwan's 2017 extension of the bevacizumab PTDL from 24 to 36 weeks in metastatic colorectal cancer (mCRC) to evaluate whether prolonged ...
Wei‐Ming Huang, Chen‐Han Chueh, Chien‐Yu Tseng, Christopher N. Kaufmann, Earl J. Morris, Chiao‐En Wu, Yi‐Wen Tsai   +6 more
wiley   +1 more source

Maximum persistent Betti numbers of Čech complexes. [PDF]

J Appl Comput Topol
Edelsbrunner H, Kahle M, Kanazawa S.
europepmc   +1 more source

Cannabinoids and drug–drug pharmacokinetic interactions: Deciphering the risks

British Journal of Clinical Pharmacology, EarlyView.
The relationship between cannabinoids and mental health has become a major focus of scientific inquiry and public discourse. Cannabinoids are diverse chemical compounds from the Cannabis species that have been explored for their therapeutic applications in treating chronic pain, psychiatric and neurological conditions, such as depression, schizophrenia,
Paraskevi Papakyriakopoulou, Georgia Valsami, Georgios Ismailos   +2 more
wiley   +1 more source

Prevalence and determinants of vascular aging in Austria - a holistic view: the LEAD study. [PDF]

J Hypertens
Azizzadeh M, Karimi A, Danninger K, Breyer MK, Breyer-Kohansal R, König A, Kaufmann CC, Boutouyrie P, Bruno RM, Mayer CC, Jäger B, Hartl S, Burghuber OC, Weber T.   +13 more
europepmc   +1 more source

How the HTAR will contribute to a value‐based decision‐making for medicinal products across the EU

British Journal of Clinical Pharmacology, EarlyView.
The European Union Health Technology Regulation 2021/2282 (HTAR) introduces joint assessment of health technologies (including medicinal products and medical devices) across EU Member States. It was signed into law in 2021 and came into full force in January 2025.
Roisin Adams, Michal Stanak
wiley   +1 more source

Mid-Infrared Spectroscopy for the Qualitative and Quantitative Analysis of the Wheat Proteome. [PDF]

Anal Chem
Nadeak DL, Wiederstein M, Baumgartner S, Reiter E, Krska R, Freitag S.   +5 more
europepmc   +1 more source